Medical News

RSS

RVO advances PresbyLens into final phase of trial for treatment of presbyopia

ReVision Optics, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, announces the advancement of its proprietary product PresbyLens into the final phase of its U.S. clinical trial under an Investigational Device Exemption

12 Jun 2012

Individuals on statins more likely to experience fatigue with exertion

In a study of more than 1,000 adults, researchers at the University of California, San Diego, found that individuals taking cholesterol-lowering statin drugs are more likely than non-users to experience decreased energy, fatigue upon exertion, or both. The researchers suggest that these findings should be taken into account by doctors when weighing risk versus benefit in prescribing statins.

12 Jun 2012

Enzo Biochem third quarter total revenue increases 4% to $26 million

Enzo Biochem, Inc. today reported results for the fiscal third quarter ended April 30, 2012.

12 Jun 2012

Children of older fathers inherit longer telomeres

If your father and grandfather waited until they were older before reproducing, you might experience life-extending benefits. Biologists assume that a slow pace of aging requires that the body invest more resources in repairing cells and tissues.

12 Jun 2012

MVP receives European patent for PEG conjugates of interferon-beta-1b to treat MS

Mountain View Pharmaceuticals, Inc. announced its receipt of European Patent No. 1 667 708 B1, titled "Polyethylene Glycol Conjugates of Interferon-beta-1b with Enhanced in vitro Biological Potency."

12 Jun 2012

BioMed Realty enters definitive agreement to acquire Granta Park

BioMed Realty Trust, Inc. today announced that it has entered into a definitive agreement to acquire Granta Park, comprising eleven laboratory and office buildings and a total of approximately 472,200 square feet of space, as well as approximately 138,400 square feet of development and expansion rights, in Cambridge, United Kingdom. The purchase price for the property is 126.8 million pounds, or approximately $196.0 million, excluding transaction costs.

11 Jun 2012

Viewpoints: Hoping that 'Gang of Six' will cut fiscal deal; Sen. Alexander links health law and college tuition increases

The public has a famously low opinion of Congress, even though people tend to hold a less disparaging view of their own representatives. The last two years have been especially tough on the institution's reputation, a response to the body's relentless brinkmanship and paralyzing partisanship in the face of a slow economy. So it is with some trepidation that I throw out a little love for a handful of senators still seeking bipartisan agreement on a plan to bring the federal government back to fiscal responsibility.

11 Jun 2012

Rheumatoid arthritis infection risk predicted by RABBIT

The RABBIT risk score can predict the likelihood of serious infection in rheumatoid arthritis patients using tumor necrosis factor-alpha inhibitors and disease-modifying antirheumatic drugs, research confirms.

11 Jun 2012

Accumulated CT radiation dose triples pediatric cancer risk

The use of computed tomography scans should be minimized in children, recommend researchers who have found a significantly increased risk for malignancy with repeated imaging.

11 Jun 2012

Investigational drug slows metastatic breast cancer progression

Trastuzumab emtansine significantly delays disease progression compared with standard therapy in women with human epidermal growth factor receptor-2-positive metastatic breast cancer, show study data presented at the American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, USA.

11 Jun 2012

Bedside cardiac ultrasound could be taught during residency

Incorporating cardiovascular limited ultrasound exam training for bedside use into the internal medicine residency curriculum is feasible, report US researchers.

11 Jun 2012

Antibacterial cloths could reduce geriatric MRSA

Using disposable antibacterial cloths to bathe elderly patients reduces the transmission rate of methicillin-resistant Staphylococcus aureus, show Canadian study results.

11 Jun 2012

ColoPrint aids prediction of colorectal cancer relapse

A novel microarray-based 18-gene expression tool known as ColoPrint significantly improves prognostic accuracy in stage II colon cancer patients who have undergone surgery, suggest study findings.

11 Jun 2012